Ad C. van Nuenen

1.2k total citations
22 papers, 692 citations indexed

About

Ad C. van Nuenen is a scholar working on Virology, Infectious Diseases and Immunology. According to data from OpenAlex, Ad C. van Nuenen has authored 22 papers receiving a total of 692 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Virology, 14 papers in Infectious Diseases and 10 papers in Immunology. Recurrent topics in Ad C. van Nuenen's work include HIV Research and Treatment (15 papers), HIV/AIDS drug development and treatment (11 papers) and Immune Cell Function and Interaction (7 papers). Ad C. van Nuenen is often cited by papers focused on HIV Research and Treatment (15 papers), HIV/AIDS drug development and treatment (11 papers) and Immune Cell Function and Interaction (7 papers). Ad C. van Nuenen collaborates with scholars based in Netherlands, United States and United Kingdom. Ad C. van Nuenen's co-authors include Hanneke Schuitemaker, Evelien M. Bunnik, Neeltje A. Kootstra, B A van der Zeijst, Marc M. S. M. Wösten, Meike H. van der Ree, Esther D. Quakkelaar, Brigitte Boeser‐Nunnink, Harry L.A. Janssen and Søren Ottosen and has published in prestigious journals such as The EMBO Journal, PLoS ONE and Journal of Virology.

In The Last Decade

Ad C. van Nuenen

21 papers receiving 686 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ad C. van Nuenen Netherlands 12 285 246 240 205 117 22 692
Hichem Lahouassa France 10 644 2.3× 272 1.1× 347 1.4× 540 2.6× 247 2.1× 16 1.1k
Jonathan Rosenberg United States 4 341 1.2× 248 1.0× 203 0.8× 260 1.3× 77 0.7× 9 677
Ayaka Okada Japan 13 67 0.2× 77 0.3× 324 1.4× 105 0.5× 72 0.6× 52 549
S. A. Jeffs United Kingdom 15 246 0.9× 97 0.4× 253 1.1× 214 1.0× 96 0.8× 33 645
Carl Zingmark Sweden 16 90 0.3× 182 0.7× 692 2.9× 67 0.3× 68 0.6× 24 900
Renu Dudani Canada 18 28 0.1× 242 1.0× 429 1.8× 689 3.4× 176 1.5× 37 1.1k
Anthony L. Desbien United States 15 115 0.4× 194 0.8× 216 0.9× 470 2.3× 166 1.4× 20 738
Michael Marotta United States 11 217 0.8× 136 0.6× 269 1.1× 162 0.8× 115 1.0× 15 669
Jean‐Hervé Colle France 17 283 1.0× 113 0.5× 144 0.6× 502 2.4× 227 1.9× 45 864
Myung‐Chul Chung United States 14 69 0.2× 108 0.4× 473 2.0× 104 0.5× 53 0.5× 19 613

Countries citing papers authored by Ad C. van Nuenen

Since Specialization
Citations

This map shows the geographic impact of Ad C. van Nuenen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ad C. van Nuenen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ad C. van Nuenen more than expected).

Fields of papers citing papers by Ad C. van Nuenen

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ad C. van Nuenen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ad C. van Nuenen. The network helps show where Ad C. van Nuenen may publish in the future.

Co-authorship network of co-authors of Ad C. van Nuenen

This figure shows the co-authorship network connecting the top 25 collaborators of Ad C. van Nuenen. A scholar is included among the top collaborators of Ad C. van Nuenen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ad C. van Nuenen. Ad C. van Nuenen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Kootstra, Neeltje A., Ad C. van Nuenen, Theresa M. Rossouw, et al.. (2024). Specific plasma microRNAs are associated with CD4+ T-cell recovery during suppressive antiretroviral therapy for HIV-1. AIDS. 38(6). 791–801.
2.
Hamme, John L. van, et al.. (2023). SARS-CoV-2 suppresses TLR4-induced immunity by dendritic cells via C-type lectin receptor DC-SIGN. PLoS Pathogens. 19(10). e1011735–e1011735. 11 indexed citations
3.
Álvarez, Guzmán, Xavier Robert, Ad C. van Nuenen, et al.. (2022). Identification of 2-(4-N,N-Dimethylaminophenyl)-5-methyl-1-phenethyl-1H-benzimidazole targeting HIV-1 CA capsid protein and inhibiting HIV-1 replication in cellulo. BMC Pharmacology and Toxicology. 23(1). 43–43. 1 indexed citations
4.
Hamme, John L. van, Philip J. M. Brouwer, Mitch Brinkkemper, et al.. (2022). SARS‐CoV‐2 infection activates dendritic cells via cytosolic receptors rather than extracellular TLRs. European Journal of Immunology. 52(4). 646–655. 11 indexed citations
5.
Nuenen, Ad C. van, et al.. (2021). Nef Obtained from Individuals with HIV-1 Vary in Their Ability to Antagonize SERINC3- and SERINC5-Mediated HIV-1 Restriction. Viruses. 13(3). 423–423. 10 indexed citations
6.
Jiménez, Viviana Cobos, Fernando O. Martínez, Karel A. van Dort, et al.. (2021). CD9 and ITGA3 are regulated during HIV-1 infection in macrophages to support viral replication. Virology. 562. 9–18. 7 indexed citations
7.
Kaptein, Tanja M., John L. van Hamme, Leanne C. Helgers, et al.. (2021). Infection and transmission of SARS‐CoV‐2 depend on heparan sulfate proteoglycans. The EMBO Journal. 40(20). e106765–e106765. 58 indexed citations
8.
Ree, Meike H. van der, Louis Jansen, Ad C. van Nuenen, et al.. (2017). Plasma MicroRNA Levels Are Associated With Hepatitis B e Antigen Status and Treatment Response in Chronic Hepatitis B Patients. The Journal of Infectious Diseases. 215(9). 1421–1429. 46 indexed citations
9.
Ree, Meike H. van der, F. Stelma, Sophie B. Willemse, et al.. (2017). Immune responses in DAA treated chronic hepatitis C patients with and without prior RG-101 dosing. Antiviral Research. 146. 139–145. 13 indexed citations
10.
Ree, Meike H. van der, Rozanne C. de Veer, Ad C. van Nuenen, et al.. (2015). Miravirsen dosing in chronic hepatitis C patients results in decreased microRNA‐122 levels without affecting other microRNAs in plasma. Alimentary Pharmacology & Therapeutics. 43(1). 102–113. 125 indexed citations
11.
Nuenen, Ad C. van, Alba Torrents de la Peña, Emma J. Bowles, et al.. (2014). Low level of HIV-1 evolution after transmission from mother to child. Scientific Reports. 4(1). 5079–5079. 7 indexed citations
12.
Feenstra, K. Anton, Ad C. van Nuenen, Marjon Navis, et al.. (2013). HIV-1 Replication Fitness of HLA-B*57/58:01 CTL Escape Variants Is Restored by the Accumulation of Compensatory Mutations in Gag. PLoS ONE. 8(12). e81235–e81235. 13 indexed citations
13.
Nuenen, Ad C. van, et al.. (2012). Gag sequence variation in a human immunodeficiency virus type 1 transmission cluster influences viral replication fitness. Journal of General Virology. 94(2). 354–359. 2 indexed citations
14.
Bunnik, Evelien M., Marit J. van Gils, Nening M. Nanlohy, et al.. (2010). Emergence of monoclonal antibody b12-resistant human immunodeficiency virus type 1 variants during natural infection in the absence of humoral or cellular immune pressure. Journal of General Virology. 91(5). 1354–1364. 6 indexed citations
15.
Bunnik, Evelien M., et al.. (2009). Escape from autologous humoral immunity of HIV-1 is not associated with a decrease in replicative capacity. Virology. 397(1). 224–230. 14 indexed citations
17.
Bunnik, Evelien M., et al.. (2008). Autologous Neutralizing Humoral Immunity and Evolution of the Viral Envelope in the Course of Subtype B Human Immunodeficiency Virus Type 1 Infection. Journal of Virology. 82(16). 7932–7941. 134 indexed citations
18.
Quakkelaar, Esther D., Floris P. J. van Alphen, Brigitte Boeser‐Nunnink, et al.. (2007). Susceptibility of Recently Transmitted Subtype B Human Immunodeficiency Virus Type 1 Variants to Broadly Neutralizing Antibodies. Journal of Virology. 81(16). 8533–8542. 21 indexed citations
19.
Quakkelaar, Esther D., Evelien M. Bunnik, Floris P. J. van Alphen, et al.. (2007). Escape of human immunodeficiency virus type 1 from broadly neutralizing antibodies is not associated with a reduction of viral replicative capacity in vitro. Virology. 363(2). 447–453. 17 indexed citations
20.
Quakkelaar, Esther D., Tim Beaumont, Ad C. van Nuenen, et al.. (2006). T cell line passage can select for pre-existing neutralization-sensitive variants from the quasispecies of primary human immunodeficiency virus type-1 isolates. Virology. 359(1). 92–104. 7 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026